Q fever: an under-reported reportable communicable disease

The objective of this study was to provide real-world clinical laboratory-based data to supplement Centers for Disease Control and Prevention (CDC) reporting of Q fever. We analysed titre results of specimens submitted to a large US clinical laboratory for Coxiella burnetii IgG antibody testing from...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Epidemiology and infection 2018-07, Vol.146 (10), p.1240-1244
Hauptverfasser:	Kaufman, Harvey W, Chen, Zhen, Radcliff, Jeff, Batterman, Hollis J, Leake, John
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Aged Antibodies, Bacterial - blood Antigens Chronic Disease Chronic illnesses Coxiella burnetii - immunology Disease control Disease Notification Disease prevention Epidemiological Monitoring Epidemiology Female Fever Health risk assessment Health surveillance Humans IgG antibody Immunoglobulin G Immunoglobulin G - blood Immunoglobulins Incidence Infections Infectious diseases Male Medical laboratories Middle Aged Morbidity Mortality Original Paper Public health Q fever Q Fever - blood Q Fever - diagnosis Q Fever - epidemiology Seroepidemiologic Studies Trends United States - epidemiology Zoonoses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The objective of this study was to provide real-world clinical laboratory-based data to supplement Centers for Disease Control and Prevention (CDC) reporting of Q fever. We analysed titre results of specimens submitted to a large US clinical laboratory for Coxiella burnetii IgG antibody testing from 2010 through 2016. Presumptive Q fever was defined as acute (phase II IgG titre ⩾1:128, phase I titre
ISSN:	0950-2688 1469-4409
DOI:	10.1017/S0950268818001395